BEVERLY HILLS, Calif. -- (BUSINESS WIRE) -- TOMI Environmental Solutions, Inc. (“TOMI” or the “Company”) (OTCQB: TOMZ), a global bacteria decontamination and infectious disease control company, announced that it will showcase its SteraMist™ System both at IDWeek, the combined annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), and the Pediatric Infectious Diseases Society (PIDS) in San Francisco, California from October 2-6, 2013 and at the 2013 Annual Meeting of American Association of Tissue Banks (AATB) at National Harbor, Maryland from October 1-5, 2013.
Dr. Halden Shane, TOMI’s Chief Executive Officer, stated “We are excited to be exhibiting this week in San Francisco at IDWeek, the combined annual meeting of the IDSA, SHEA, HIVMA and PIDS. This annual meeting brings together more than 5,500 professional attendees from more than 80 countries. These two different venues, on both U.S. coasts, have one thing in common: the need for a proven time-tested technology to assist in the control of today’s emerging infectious diseases. IDWeek’s website notes that this year’s theme is ”Advancing Science, Improving Care.” IDWeek features the latest science and bench-to-bedside approaches in prevention, diagnosis, treatment and epidemiology of infectious diseases.” SteraMist/BIT™’s (Binary Ionization Technology®) is an innovative, patented no-touch technology, which utilizes an activated aerosolized hydrogen peroxide (H2O2) to effectively address bio-decontamination situations, on all microorganisms.
In addition to exhibiting at IDWeek this week, TOMI will also be exhibiting this week its technology at AATB Annual Meeting, at National Harbor, Maryland. Currently, TOMI’s novel SteraMist™ technology, powered by BIT (Binary Ionization Technology®), is being used in various tissue banks across the country in conjunction with their overall goal to help safeguard the environment at these tissues banks. Mark Futrovsky, TOMI’s President, stated, “TOMI is pleased to be a part of the AATB Annual Meeting. We all probably know someone whose life has been positively changed though the gift of donated cells or tissues, and are very cognizant of the AATB’s safety concerns.” As noted on their website, the AATB is the only national tissue banking organization in the United States and its membership totals more than 100 accredited tissue banks and 1,000 individual members. These banks recover tissue from more than 30,000 donors and distribute in excess of two million allografts for more than one million tissue transplants performed annually in the U.S.
Please visit us at booth #820 at IDWeek in San Francisco and at booth #106 at AATB in National Harbor, Maryland.
About TOMI™ Environmental Solutions, Inc.
TOMI™ Environmental Solutions, Inc. (OTCQB: TOMZ) is a global bacteria decontamination and infectious disease control company, providing green energy-efficient environmental solutions for indoor surface decontamination through manufacturing, sales and licensing of our premier platform of Hydrogen Peroxide aerosols, Ultra-Violet Ozone Generators and Ultra-Violet Germicidal Irradiation ("UVGI") products and technologies.
TOMI’s products are designed to service a broad spectrum of commercial structures including medical facilities, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, and athletic facilities. TOMI™’s products and services have also been used in single-family homes and multi-unit residences.
TOMI™ also develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, The Restoration Industry Association, Indoor Air Quality Association and The International Ozone Association.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. Because they are forward-looking, they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.